Back to search

Article

A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex

2026-07-16

Abstract excerpt

Targeted protein degradation enables the elimination of disease-relevant proteins through induced proximity between E3 ligases and substrates. Current androgen receptor (AR) therapies act via the ligand-binding domain (LBD) but fail against constitutively active LBD mutants or splice variants such as AR-V7. Here, we identify GZL626, a small-molecule degrader that induces proteasome-dependent degradation of both fu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf5f4f03-0b0c-5402-a7fb-f501ebc0a78e
DOI
10.64898/2026.07.14.738453
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complexDOI 10.64898/2026.07.14.738453
Select a neighboring publication to make it the new centre.